Global RNAi Therapeutic Market Accelerates with Breakthrough Gene-Silencing Innovations
Global RNAi for therapeutic market is undergoing a period of unprecedented expansion, driven by rapid advancements in gene-silencing technologies and the growing shift toward precision medicine. Valued at USD 327 million in 2024, the market is projected to surge to USD 4,523 million by 2031, registering a remarkable CAGR of 46.7% during the forecast period. … Read more